Vascular Pharmacology

Papers
(The TQCC of Vascular Pharmacology is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Corrigendum to “Elucidating the crosstalk between endothelial-to-mesenchymal transition (EndoMT) and endothelial autophagy in the pathogenesis of atherosclerosis” [Vascular Pharmacology 155 (2024) 107106
Patterns of medication use and potential drug-drug interactions in post-PCI patients: A study from Iran100
Graphical abstract TOC48
Biobanks: The unmet need in heart failure management37
Graphical abstract TOC36
The transfer of gut microbiota/metabolites from children to mice affects cardiometabolic development and induces sex-dimorphism in recipients34
Animal experimental models of ischemic limbs – A systematic review25
Therapy and guideline adherence at a multidisciplinary hypertension clinic: A prospective, observational study24
Molecular mechanisms of flavonoids in myocardial ischemia reperfusion injury: Evidence from in-vitro and in-vivo studies23
The MEK-ERK-Egr-1 axis and its regulation in cardiovascular disease23
Prevalence of antiphospholipid antibodies in COVID-19 patients: A meta-analysis23
A random shuffle method to expand a narrow dataset: A heart failure cohort example22
Editorial Board22
Exploiting endothelial functions in bone regenerative medicine21
Optical stimulation of endothelial colony forming cells plated on light-sensitive conjugated polymers induces a TRPV1-mediated increase in intracellular Ca2+ concentration20
Doxorubicin-induced cardiotoxicity enhance SARS-CoV-2 infection susceptibility in human cardiomyocytes20
Prevention of cardiovascular complications in elderly cancer patients20
Editorial Board19
Editorial Board19
The future of group 2 pulmonary hypertension: Exploring clinical trials and therapeutic targets18
Interaction of FOXO1 and SUMOylated PPARγ1 induced by hyperlipidemia and hyperglycemia favors vascular endothelial insulin resistance and dysfunction17
Adipsin in the pathogenesis of cardiovascular diseases17
Global and endothelial G-protein coupled receptor 75 (GPR75) knockout relaxes pulmonary artery and mitigates hypoxia-induced pulmonary hypertension17
Diabetic neuropathy: Molecular approach a treatment opportunity16
Changes in arterial myocyte excitability induced by subarachnoid hemorrhage in a rat model16
Diabetes and vascular disease: New therapeutic avenues16
MicroRNAs and their regulators: Potential therapeutic targets in pulmonary arterial hypertension16
Ticagrelor inhibits platelet aggregation and reduces inflammatory burden more than clopidogrel in patients with stages 4 or 5 chronic kidney disease16
Indobufen versus aspirin in patients with indication for antiplatelet therapy: A systematic review and meta-analysis16
Targeting the Ca2+ signaling toolkit as an alternative strategy to mitigate SARS-CoV-2-induced cardiovascular adverse events15
The impact of proangiogenic microRNA modulation on blood flow recovery following hind limb ischemia. A systematic review and meta-analysis of animal studies15
Deleterious effects of levamisole, a cocaine adulterant, in rabbit aorta15
Vitamin D deficiency is associated with impaired reperfusion in STEMI patients undergoing primary percutaneous coronary intervention15
Graphical abstract TOC14
Β-blockers activate autophagy on infantile hemangioma-derived endothelial cells in vitro14
Graphical abstract TOC14
Interplay between CD28 and PD-1 in T cell immunotherapy14
A novel multidisciplinary approach in an LMNA-mutated patient: the importance of considering the overall clinical picture for the early diagnosis14
Circulating osteonectin predicts postural imbalance and cardiac dysfunction in heart failure14
Novel NLRP3 inflammasome inhibitors INF150 and INF195 attenuate isoproterenol-induced hypertrophy in H9c2 rat cardiac myoblast13
Graphical abstract TOC13
Trimethylamine N-oxide (TMAO) impact on endothelial dysfunction: An in vitro study using bovine aortic endothelial cells13
Editorial Board13
Bruton's Tyrosine Kinase inhibition by Acalabrutinib does not affect early or advanced atherosclerotic plaque size and morphology in Ldlr mice12
Myocardial energy balance and metabolism as causes of myocardial ischemia12
3-methoxycatechol causes vasodilation likely via KV channels: ex vivo, in silico docking and in vivo study12
Angina pectoris 2023: With and without obstructive coronary artery disease: Epidemiology, diagnosis, prognosis, and treatment12
Sexual dimorphism in aortic aneurysm: A review of the contributions of sex hormones and sex chromosomes12
The diverging roles of insulin-like growth factor binding proteins in pulmonary arterial hypertension12
Dynamic co-culture of endothelial and smooth muscle cells as a platform for pathophysiological investigations of vascular calcifications12
The use of specific antihypertensive medication and skin cancer risk: A systematic review of the literature and meta-analysis12
Assessment of ACE1 variants and ACE1/ACE2 expression in COVID-19 patients12
Clinical outcomes and safety of sotatercept in pulmonary arterial hypertension: A systematic review and meta-analysis of randomized controlled trials12
Corrigendum to “Non-coding RNAs regulate angiogenic processes” [Vascular pharmacology 133–134 (2020) 106778]11
GYY4137, a hydrogen sulfide donor, protects against endothelial dysfunction in porcine coronary arteries exposed to myeloperoxidase and hypochlorous acid11
Inflammation and the pathogenesis of atherosclerosis11
Editorial Board11
Zinc alpha 2-glycoprotein associates with features of plaque stability in patients with carotid atherosclerosis10
The influence of environmental hypoxia on the goldfish (Carassius auratus) heart: From functional responses to mitochondrial molecular mechanisms10
A treatment algorithm for ischemic cardiomyopathy10
Comparative analysis of antiproliferative and vasodilator effects of drugs for pulmonary hypertension: Extensive in vitro study in rats and human10
Graphical abstract TOC10
Istaroxime follow-on compounds: A new class of selective SERCA2a activators for chronic heart failure treatment10
Effects of simvastatin treatment on leptomeningeal collateral vessels: resistance, number and diameter9
Extracellular vesicles (EVs) in ischemic conditioning and angiogenesis: Focus on endothelial derived EVs9
Association of MMP9 with adverse features of plaque progression and residual inflammatory risk in patients with chronic coronary syndrome (CCS)9
The role of histone modifications in pulmonary hypertension: From mechanisms to therapeutic targets9
Potency of miR-144-3p in promoting abdominal aortic aneurysm progression in mice correlates with apoptosis of smooth muscle cells9
Advancements in non-invasive hyperspectral imaging: Mapping blood oxygen levels and vascular health for clinical and research applications9
Roles of endothelial and smooth muscle cell dysfunction and vasa vasorum in vasomotor disorders in ischemia with no obstructive coronary artery disease9
Eighty years of oral anticoagulation: Learning from history9
Vascular diameter determines sensitivity to soluble guanylate cyclase activation in human mesenteric and renal arteries8
Immune response following transcatheter aortic valve procedure8
Empagliflozin decreases ageing-associated arterial stiffening and vascular fibrosis under normoglycemic conditions8
Long-term dietary n3 fatty acid prevents aging-related cardiac diastolic and vascular dysfunction8
Relevance of real-time analyzers to determine mitochondrial quality in endothelial cells and oxidative stress in preeclampsia8
17β-estradiol promotes angiogenesis through non-genomic activation of Smad1 signaling in endometriosis7
Challenges facing the clinical translation of cardioprotection: 35 years after the discovery of ischemic preconditioning7
Optimal medical therapy vs revascularization in chronic coronary syndromes: Does ISCHEMIA move the needle toward or away from revascularization??7
Endothelial leptin receptor is dispensable for leptin-induced sympatho-activation and hypertension in male mice7
Resolvin D2 limits senescent cell accumulation in atherosclerotic plaques7
PI3KC2α: A novel key player in cardiac contractility and DOX-induced cardiotoxicity?7
Bioactive lipids improve serum HDL and PON1 activities in coronary artery disease patients: Ex-vivo study7
Multi-omics identification of quantitative trait loci associated with vascular pathogenesis and diagnostic potential in chronic venous disease7
TLR4-Myd88 pathway upregulated caveolin-1 expression contributes to coronary artery spasm7
MELAS syndrome: Insights into cardiac mechanics7
Contents continued7
Catestatin as a key attenuator of cardiac inflammation in hypertension: Role of macrophage immunosuppression7
Editorial Board7
Amyloid-β: A potential mediator of aging-related vascular pathologies7
The selective deletion of tyrosyne hydroxylase gene in the endothelium affects cardiovascular function7
Plasma exosomes after PCI in non-diabetic STEMI patients fed barley beta-D-glucan-enriched pasta reduce oxidative stress-induced endothelial cell senescence7
Editorial Board6
Is remote conditioning cardioprotection temperature dependent?6
Sodium nitroprusside for advanced heart failure. A metanalysis of literature data6
From cine-MRI to computational models of blood flow within the heart6
Optogenetic manipulation of cardiac electrical dynamics using sub-threshold illumination: Dissecting the role of cardiac alternans in terminating rapid rhythms6
The life cycle of a capillary: Mechanisms of angiogenesis and rarefaction in microvascular physiology and pathologies6
Graphical abstract TOC6
Extracellular stiffness as a determinant of cardiac dysfunction in Duchenne's muscular dystrophy: A study on human iPSC-derived cardiomyocytes6
Stay connected: The myoendothelial junction proteins in vascular function and dysfunction6
The short-chain fatty acid butyrate accelerates vascular calcification via regulation of histone deacetylases and NF-κB signaling6
Macrophage-mediated downregulation of lncRNA Carmn in mouse abdominal aortic aneurysm6
Stimulation of angiotensin II receptor 2 preserves cognitive function and is associated with an enhanced cerebral vascular density after stroke6
Endothelial dysfunction in acute and long standing COVID−19: A prospective cohort study6
Melatonin treatment during chronic hypoxic gestation improves neonatal cerebrovascular function6
Effects of mavacamten in human myocardium from hypertrophic obstructive cardiomyopathy (HOCM) patients: A comparison with disopyramide6
Exploring bradykinin: A common mediator in the pathophysiology of sepsis and atherosclerotic cardiovascular disease6
Matrix metalloproteinases in aortic dissection6
Graphical abstract TOC6
Risk stratification of patients with SARS-CoV-2 by tissue factor expression in circulating extracellular vesicles6
Different gene expression patterns between mouse and human brain pericytes revealed by single-cell/nucleus RNA sequencing5
Graphical abstract TOC5
An intrinsic mechanism of metabolic resilience influences the cardiac response to stress5
Emerging therapies in dyslipidaemias5
Mitochondrial DNA and TLR9 activation contribute to SARS-CoV-2-induced endothelial cell damage5
Perivascular adipose tissue-derived nitric oxide compensates endothelial dysfunction in aged pre-atherosclerotic apolipoprotein E-deficient rats5
The crosstalk between lipopolysaccharide-induced septic myocardial dysfunction and cardiac lipotoxicity: Toll like receptor 4 as common target of the novel cardioprotective peptide cateslytin5
LncRNA MYOSLID contributes to PH via targeting BMPR2 signaling in pulmonary artery smooth muscle cell5
Empagliflozin restores autophagy and attenuates ponatinib-induced cardiomyocyte senescence and death5
Beta-blockers in pulmonary arterial hypertension: Time for a second thought?5
Apoptosis signal-regulating kinase-1 regulates thrombin-induced endothelial permeability5
Emerging effects of non-coding RNA in vascular endothelial cells during strokes5
Graphical abstract TOC5
The potential role of thymoquinone in preventing the cardiovascular complications of COVID-195
Frataxin deficiency disrupts mitochondrial respiration and pulmonary endothelial cell function5
Elucidating emerging signaling pathways driving endothelial dysfunction in cardiovascular aging5
Contents continued5
Editorial Board5
Understanding the pathobiology of intermediate filaments to curb acute and chronic cardiac dysfunction5
0.22035503387451